MeiraGTx Holdings Equity 2024

MeiraGTx Holdings Aktienanalyse

What does MeiraGTx Holdings do?

MeiraGTx Holdings PLC is a leading company in the field of gene therapy and develops innovative therapies for various genetic diseases. The company was founded in 2015 and is headquartered in London, UK, with additional locations in the USA. MeiraGTx aims to change lives by developing gene therapy-based drugs that enable a cure or permanent relief from serious illnesses. History: MeiraGTx was founded by renowned genome researcher Dr. Gregory A. Petsko and an experienced team of scientists and experts in the biotechnology and pharmaceutical fields. With an experienced team and significant investment capital, MeiraGTx has established itself as a leading company in the field of gene therapy. Business model: MeiraGTx has a unique business model based on an innovative platform technology that enables the company to develop gene therapies for various diseases. The company works with a variety of technologies, including AAV vectors, DNA targeted integration, gene editing platform, and more. By combining these technologies, MeiraGTx can develop gene therapies tailored to the individual's condition. Segments: MeiraGTx consists of various divisions and products that focus on the development of therapeutics for various genetic diseases. Ophthalmology: MeiraGTx develops gene therapies for retinal diseases such as retinitis pigmentosa and macular degeneration. These therapies have the potential to preserve or even improve vision. Neurology: MeiraGTx develops therapeutics for neurological diseases such as Parkinson's and Huntington's. These gene therapies have the potential to alleviate the symptoms of the disease and improve the patient's quality of life. Hemophilia: MeiraGTx has developed gene therapies for hemophilia A and B based on its gene editing platform technology. These therapies have the potential to significantly improve the lives of hemophilia patients. Other products and therapies: MeiraGTx is also working on the development of gene therapies for cancer, cystic fibrosis, cardiovascular diseases, and autoimmune diseases. Summary: MeiraGTx is a leading company in the field of gene therapy and is committed to developing innovative therapeutics for various genetic diseases. With the help of technologies such as AAV vectors, DNA targeted integration, gene editing platform, and more, the company has the potential to change the lives of millions of patients. MeiraGTx is on track to revolutionize the healthcare industry, and it will be exciting to see what future advances the company will achieve. MeiraGTx Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing MeiraGTx Holdings's Equity

MeiraGTx Holdings's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding MeiraGTx Holdings's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating MeiraGTx Holdings's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

MeiraGTx Holdings's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in MeiraGTx Holdings’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about MeiraGTx Holdings Stock

What is the equity of MeiraGTx Holdings this year?

MeiraGTx Holdings has equity of 138.18 M USD this year.

What was the equity of MeiraGTx Holdings compared to the previous year?

The equity of MeiraGTx Holdings has increased/decreased by 17.4% increased compared to the previous year.

What impact does a high equity have on investors of MeiraGTx Holdings?

A high equity is advantageous for investors of MeiraGTx Holdings as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of MeiraGTx Holdings?

A low equity can be a risk for investors of MeiraGTx Holdings, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of MeiraGTx Holdings affect the company?

An increase in equity of MeiraGTx Holdings can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of MeiraGTx Holdings affect the company?

A reduction in equity of MeiraGTx Holdings can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of MeiraGTx Holdings?

Some factors that can affect the equity of MeiraGTx Holdings include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of MeiraGTx Holdings so important for investors?

The equity of MeiraGTx Holdings is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can MeiraGTx Holdings take to change the equity?

To change equity, MeiraGTx Holdings can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does MeiraGTx Holdings pay?

Over the past 12 months, MeiraGTx Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MeiraGTx Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of MeiraGTx Holdings?

The current dividend yield of MeiraGTx Holdings is .

When does MeiraGTx Holdings pay dividends?

MeiraGTx Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of MeiraGTx Holdings?

MeiraGTx Holdings paid dividends every year for the past 0 years.

What is the dividend of MeiraGTx Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is MeiraGTx Holdings located?

MeiraGTx Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von MeiraGTx Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of MeiraGTx Holdings from 6/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.

When did MeiraGTx Holdings pay the last dividend?

The last dividend was paid out on 6/19/2024.

What was the dividend of MeiraGTx Holdings in the year 2023?

In the year 2023, MeiraGTx Holdings distributed 0 USD as dividends.

In which currency does MeiraGTx Holdings pay out the dividend?

The dividends of MeiraGTx Holdings are distributed in USD.